Volume 18, Number 3—March 2012
High Incidence of Group B Streptococcal Infection in Infants Born to HIV-Infected Mothers
Highlight and copy the desired format.
|EID||Goetghebuer T, Adler C, Epalza C, Levy J. High Incidence of Group B Streptococcal Infection in Infants Born to HIV-Infected Mothers. Emerg Infect Dis. 2012;18(3):539-540. https://dx.doi.org/10.3201/eid1803.111630|
|AMA||Goetghebuer T, Adler C, Epalza C, et al. High Incidence of Group B Streptococcal Infection in Infants Born to HIV-Infected Mothers. Emerging Infectious Diseases. 2012;18(3):539-540. doi:10.3201/eid1803.111630.|
|APA||Goetghebuer, T., Adler, C., Epalza, C., & Levy, J. (2012). High Incidence of Group B Streptococcal Infection in Infants Born to HIV-Infected Mothers. Emerging Infectious Diseases, 18(3), 539-540. https://dx.doi.org/10.3201/eid1803.111630.|
To the Editor: In their cross-sectional study comparing group B streptococcus (GBS) carriage among HIV-infected and HIV-uninfected women in Malawi, Gray et al. found no differences in GBS carriage between both groups but found a higher carriage rate for HIV-infected women with high CD4 cell counts (1). They proposed that a GBS-specific immune defect might exist in HIV-infected pregnant women and suggested that this defect could be blurred by competitive exclusion of GBS as a consequence of changes in microbial flora at lower CD4 counts.
We recently reported an increased incidence of neonatal GBS sepsis in HIV-exposed uninfected (HEU) infants born in Belgium, compared with the general population (2). In our cohort, the risk for GBS infection was 20× higher in HEU infants than in infants born to HIV-uninfected mothers. Moreover, the episodes of GBS sepsis in HEU infants, compared with the general population, were more severe and mostly of late onset. We are currently looking prospectively at GBS carriage in HIV-infected and control uninfected pregnant women to learn whether our observation can be explained by a higher carriage rate in HIV-infected women or by increased susceptibility of HEU infants to this capsulated bacteria. The latter hypothesis would be in line with the higher susceptibility of HEU children to other types of severe infections, as has been described in several studies from sub-Saharan Africa and Latin America (3–5).
The incidence of GBS sepsis in HIV-exposed infants born in Africa is unknown. In addition to the need for further investigation of anti-GBS immunity in HIV-infected pregnant women, we believe that studies comparing the incidence of neonatal GBS sepsis in HEU and HIV-unexposed infants are warranted. If the increased risk for GBS sepsis is confirmed, prophylaxis should be implemented in the population concerned.
- Gray KJ, Kafulafula G, Matemba M, Kamdolozi M, Membe G, French N, Streptococcus and HIV infection in pregnant women, Malawi, 2008–2010. Emerg Infect Dis. 2011;17:1932–5.
- Epalza C, Goetghebuer T, Hainaut M, Prayez F, Barlow P, Dediste A, High incidence of invasive group B streptococcal infections in HIV-exposed uninfected infants. Pediatrics. 2010;126:e631–8.
- Mussi-Pinhata MM, Freimanis L, Yamamoto AY, Korelitz J, Pinto JA, Cruz ML, Infectious disease morbidity among young HIV-1–exposed but uninfected infants in Latin American and Caribbean countries: the National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study. Pediatrics. 2007;119:e694–704.
- Koyanagi A, Humphrey JH, Ntozini R, Nathoo K, Moulton LH, Iliff P, Morbidity among human immunodeficiency virus–exposed but uninfected, human immunodeficiency virus–infected, and human immunodeficiency virus–unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy. Pediatr Infect Dis J. 2011;30:45–51.
- Filteau S. The HIV-exposed, uninfected African child. Trop Med Int Health. 2009;14:276–87.
Please use the form below to submit correspondence to the authors or contact them at the following address:
Tessa Goetghebuer, Hôpital Saint-Pierre–Department of Pediatrics, 322 Rue Haute, Brussels 1000, Belgium
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: February 08, 2012
- Page last updated: February 15, 2012
- Page last reviewed: February 15, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)